CD20 drugs for Diffuse Large B-Cell Lymphoma
2 tracked CD20 drugs in the Diffuse Large B-Cell Lymphoma race. The class explanation lives on the CD20 page; the full indication pipeline across every mechanism is on the Diffuse Large B-Cell Lymphoma page.
2 approved / phase 4